U.S. Professional Services Stock News

NasdaqCM:ALTO
NasdaqCM:ALTOChemicals

Alto Ingredients (ALTO) Stock Could Be 44.3% Undervalued After $8.9 Million 45Z Credit Sale

Alto Ingredients (ALTO) has drawn fresh attention after monetizing its 2025 Section 45Z Clean Fuel Production Tax Credits, securing about $8.9 million in cash that ties directly to its low-carbon ethanol operations. See our latest analysis for Alto Ingredients. That cash injection from Section 45Z tax credits lands at a time when Alto Ingredients’ share price has risen 88.53% year to date, with a 30 day share price return of 6.25% and a one year total shareholder return of 332.33%. These...
NYSE:AJG
NYSE:AJGInsurance

Arthur J. Gallagher (AJG) Stock Could Be 18.9% Undervalued on Its Digital Margin Growth Story

Arthur J. Gallagher Stock Snapshot After Recent Trading Moves Arthur J. Gallagher (AJG) stock has seen mixed short term performance, with a small decline over the past week, a gain over the past month, and a slight fall over the past 3 months. See our latest analysis for Arthur J. Gallagher. At a share price of $214.06, Arthur J. Gallagher’s 30 day share price return of 5.21% contrasts with a weaker year to date share price trend and a 1 year total shareholder return that is down 31.74%. This...
NYSE:DOC
NYSE:DOCHealth Care REITs

Will Mad Money’s “Defensive” Spotlight on Healthpeak (DOC) Recast Its Healthcare REIT Investment Narrative?

In June 2026, Healthpeak Properties announced that it had reported its second-quarter 2026 results on August 4 and hosted a follow-up earnings conference call and webcast on August 5 to review its financial and operating performance. Around the same time, prominent media coverage on Mad Money highlighted Healthpeak as a large healthcare-focused REIT with a dividend yield just under 6%, drawing fresh attention to its outpatient and senior living portfolio as a potential defensive holding...
NasdaqGS:HUBG
NasdaqGS:HUBGLogistics

What Hub Group (HUBG)'s Accounting Probe and Executive Turmoil Means For Shareholders

Earlier this month, logistics provider Hub Group (NASDAQ:HUBG) disclosed widespread accounting issues spanning 2023 to 2025, acknowledged materially misstated financial statements and ineffective internal controls, and faced sudden departures of its CFO and COO along with a NASDAQ delisting notice amid a new Hagens Berman investigation. These governance and compliance concerns emerge just as Hub Group approaches its next earnings report, adding fresh uncertainty around the reliability of its...
NYSE:JKS
NYSE:JKSSemiconductor

JinkoSolar Holding (JKS) Stock Could Be 37.4% Undervalued After RETC Recognition

JinkoSolar Holding (JKS) drew fresh investor attention after being named Overall Highest Achiever in the 2026 PV Module Index by RETC for the seventh year. This recognition underscores consistent product reliability and performance. See our latest analysis for JinkoSolar Holding. Recent price action around JinkoSolar Holding reflects mixed sentiment, with a 1-day share price return of 1.09% and 7-day gain of 4.63% set against a 30-day decline of 12.48% and year to date share price return down...
NasdaqGS:INDV
NasdaqGS:INDVPharmaceuticals

Indivior Pharmaceuticals (INDV) Stock Could Be 23% Undervalued As Cost Cut Narrative Builds

Indivior Pharmaceuticals (INDV) is back in focus after fresh attention on its role in treating opioid dependence, prompting investors to reassess the stock’s recent performance and current valuation based on publicly available financial metrics. See our latest analysis for Indivior Pharmaceuticals. The recent focus on Indivior Pharmaceuticals comes against a backdrop of steady gains, with a 30.72% 90 day share price return and a very strong 1 year total shareholder return of 175.54%,...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Magnite (MGNI) Stock Could Be 19.5% Undervalued After AI Platform Launch

Magnite (MGNI) stock has been in focus after the company introduced its Magnite Orchestration platform, which connects buyer and seller agents for AI-driven programmatic campaigns across premium inventory, along with fresh partnerships and analyst commentary. See our latest analysis for Magnite. Those launches and partnerships have arrived alongside a sharp shift in market sentiment, with Magnite’s share price returning 33.61% over the past 30 days and 44.51% over 90 days. Its 1 year total...
NYSE:RTX
NYSE:RTXAerospace & Defense

RTX (RTX) Stock Near Fair Value After $100 Million Defense Expansion

RTX (RTX) is back in focus after Raytheon committed US$100 million to expand its Portsmouth, Rhode Island facility, a move tied to higher demand for LTAMDS radar and Patriot GEM-T components. See our latest analysis for RTX. The Rhode Island expansion comes as RTX’s share price has pulled back 3.62% over the past day to US$185.60, yet still shows a 6.37% 30 day share price return and a 5 year total shareholder return of 138.56%, suggesting longer term momentum remains intact. If RTX’s defense...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

Atlanta Braves Holdings (BATR.K) Stock Could Be 32.8% Undervalued After Stronger Results

Atlanta Braves Holdings (BATR.K) is drawing fresh attention after a mix of higher quarterly revenue, improved net profit, and active institutional trading, including reduced stakes from major holders and AI driven strategies. See our latest analysis for Atlanta Braves Holdings. At a share price of $50.38, Atlanta Braves Holdings has eased slightly over the past week but still shows strong momentum, with a 90 day share price return of 21.46% and a 5 year total shareholder return of 86.94%...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Can Radware’s (RDWR) New AI Xploit Shield Deepen Its Edge In Application Security?

Radware recently launched AI Xploit Shield, an AI-powered service that automatically generates, tests, and deploys tailored protections to shield applications and APIs from newly discovered vulnerabilities during the gap before patches are applied. By targeting the shrinking window between vulnerability disclosure and exploitation, AI Xploit Shield highlights how defensive AI is becoming central to modern cybersecurity architectures. We will now examine how this AI-based virtual patching...
NYSE:WHR
NYSE:WHRConsumer Durables

Whirlpool (WHR) Is Down 8.4% After Costlier Debt Refi Tightens Earnings Cushion – Has The Bull Case Changed?

Whirlpool Corporation recently priced a tender offer to repurchase its low‑coupon euro‑denominated 1.250% 2026 and 1.100% 2027 notes via its Luxembourg subsidiary, funded by a new US$2.00 billion senior secured notes issuance and accompanied by a consent solicitation to amend the 2027 indenture. This refinancing shifts Whirlpool’s debt mix from cheaper euro funding to higher‑cost secured borrowing, easing near‑term maturities while increasing ongoing interest expenses and drawing criticism...
NasdaqGS:RMBS
NasdaqGS:RMBSSemiconductor

What Rambus (RMBS)'s DOJ Antitrust Probe and Insider Selling Flurry Means For Shareholders

Earlier this week, Rambus Inc. disclosed that it is responding to a U.S. federal grand jury subpoena tied to a Department of Justice antitrust investigation, while analysts and investors also reacted to an earlier series of insider share sales and an analyst downgrade. The combination of a high valuation signal, meaningful insider selling over the past three months, and fresh legal scrutiny has sharpened investor focus on how much risk is already reflected in Rambus’s current pricing and...
NasdaqGS:RELY
NasdaqGS:RELYDiversified Financial

Remitly Global (RELY) Stock Could Be 26% Undervalued After Peace Deal Boost

Remitly Global (RELY) is back on traders’ radar after a Trump Administration peace deal, linked to reopening the Strait of Hormuz, reduced perceived operational risks for internet focused companies with exposure to affected regions. See our latest analysis for Remitly Global. The peace deal headlines sit on top of an already strong run for Remitly Global, with the stock at $21.11 and a 90 day share price return of 37.52% and year to date share price return of 59.68%. The 3 year total...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Immunocore Holdings (IMCR) Stock Could Be 57.1% Undervalued After Annual Results

Immunocore Holdings (IMCR) continues to attract attention after reporting annual revenue of US$412.8 million and a net loss of US$27.6 million, which puts its current US$1.45b market value into sharper focus for investors. See our latest analysis for Immunocore Holdings. At a share price of US$28.59, Immunocore Holdings has seen its share price return decline 15.36% year to date, while the 1 year total shareholder return is down 9.81%. This points to cooling momentum after several years of...
NYSE:P
NYSE:PTech

Everpure (P) Stock Could Be 58.6% Undervalued After Its AI Infrastructure Push

Everpure stock (P) is in focus after the company used its Pure Accelerate 2026 event to roll out Everpure Data Stream and Everpure Data Intelligence, along with deeper partnerships with NVIDIA and Veeam around enterprise AI infrastructure. See our latest analysis for Everpure. Everpure stock has been volatile around these AI announcements, with a 1-day share price return of 2.67% and 7-day share price return of 7.60%. The 1-year total shareholder return of 41.12% and 5-year total shareholder...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

J.B. Hunt Transport Services (JBHT) Stock Could Be 7.46% Below Fair Value After Recent Pullback

J.B. Hunt Transport Services (JBHT) stock is drawing fresh attention after recent trading left it with a 1 day gain of 1.5%, offset by a 6.2% decline over the past week. See our latest analysis for J.B. Hunt Transport Services. Despite the recent 7 day share price decline and short term volatility, J.B. Hunt Transport Services still sits at a share price of $271.22, with a 30 day share price return of 5.73% and a 1 year total shareholder return of 96.99%. This suggests momentum has been...
NYSE:AOS
NYSE:AOSBuilding

Does Renewed Analyst Support and Institutional Buying Recast A. O. Smith’s (AOS) Resilience Narrative?

In recent days, Oppenheimer reaffirmed its positive view on A. O. Smith, citing the company’s replacement-driven revenue base, cost initiatives, and portfolio flexibility, even as it acknowledged near-term demand pressures and softer recent financial results. At the same time, institutional investors including BlackRock, State Street, and Fidelity have modestly increased their ownership, signaling continued confidence in A. O. Smith’s fundamentals despite recent revenue and profit...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Does Strong Identity Demand And AI Tailwinds Change The Bull Case For Okta (OKTA)?

Earlier this quarter, Okta reported quarterly results that eased concerns about AI-related disruption, highlighting ongoing demand for its identity security platform and a debt-free balance sheet supporting continued share repurchases. An interesting takeaway is that Okta framed agentic AI not as a threat but as a catalyst increasing the urgency and breadth of identity security needs. With institutions increasing their holdings and AI framed as a demand driver, we’ll now examine how this...
NYSE:KMT
NYSE:KMTMachinery

Did Kennametal’s Standout Revenue Beat Just Shift KMT’s Efficiency and Innovation Investment Narrative?

Kennametal recently reported a past quarter in which revenue increased 21.8% year on year, coming in 4.8% above analyst expectations and marking the strongest growth among its professional tools and equipment peers. This outperformance relative to competitors highlights how Kennametal’s end-market exposure and product offering are currently translating into stronger top-line momentum than the wider industry. We’ll now examine how this faster-than-peer revenue growth may influence...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Mirum Pharmaceuticals (MIRM) Is Up 8.6% After FDA Grants Priority Review to Zilurgisertib NDA

Mirum Pharmaceuticals and Incyte recently reported pivotal Phase 2 data from the PROGRESS study, showing that oral ALK2 inhibitor zilurgisertib reduced new heterotopic ossification lesion formation and flare activity in fibrodysplasia ossificans progressiva, and the FDA has accepted its New Drug Application with Priority Review. This progress in an ultra-rare disease affecting roughly 1,200 patients worldwide could add a highly differentiated asset to Mirum’s rare-disease portfolio if...
NYSE:ONTO
NYSE:ONTOSemiconductor

Onto Innovation (ONTO) Is Up 10.0% After Dragonfly G5 Adoption And Convertible Notes Offering - Has The Bull Case Changed?

In recent days, Onto Innovation reported progress in advanced packaging, including faster‑than‑planned adoption of its Dragonfly G5 inspection system, alongside a zero‑coupon US$1.30 billion convertible notes offering and fresh analyst coverage. Together, these developments highlight how Onto is leaning into higher‑value AI packaging opportunities while strengthening its balance sheet to support further growth initiatives. We’ll now examine how Onto’s accelerating Dragonfly G5 adoption...
NYSE:AIT
NYSE:AITTrade Distributors

Applied Industrial Technologies (AIT) Stock Looks Slightly Rich After Drone And AI Venture News

Applied Industrial Technologies (AIT) has drawn fresh attention after signing a Letter of Intent with ideaForge Technology to pursue a joint venture in drones, AI, and next-generation mobility, alongside recent earnings and analyst commentary. See our latest analysis for Applied Industrial Technologies. Against this backdrop, Applied Industrial Technologies’ recent Letter of Intent in drones and AI comes as the stock shows strong momentum, with a 30.17% year to date share price return and a...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Fox (FOXA) Stock Could Be 29.4% Below Fair Value After Recent Share Price Slide

Fox (FOXA) is back in focus after a recent share price move, with the stock closing at $52.23. Investors are reassessing the media company’s value using its latest financial and return figures. See our latest analysis for Fox. Recent moves in the Fox share price, including a 1-day share price return of 1.77% after a period where the 7-day share price return declined 23.53% and the year-to-date share price return declined 29.19%, contrast with a 3-year total shareholder return of 64.88%. This...
NYSE:IMAX
NYSE:IMAXEntertainment

IMAX (IMAX) Stock Could Be 5.3% Undervalued After Disclosure Day Opening Weekend

IMAX (IMAX) stock moved after Universal’s Disclosure Day delivered a robust opening weekend, with IMAX premium screens capturing nearly 15% of the film’s US$93.9 million global box office. See our latest analysis for IMAX. Beyond this weekend’s box office boost, IMAX’s recent share price momentum has been building, with a 30 day share price return of 33.97% and a 1 year total shareholder return of 51.82% reflecting how investors are reassessing both growth potential and risk. If this kind of...